ABSTRACT
We evaluated the ability of Lactobacillus delbrueckii UFV H2b20, a probiotic candidate, to stimulate the production of inflammatory cytokines and to induce macrophage activation and Th1 differentiation in peripheral blood mononuclear cells (PBMC) from healthy volunteers. Our results show that PBMC stimulated with heat-killed Lact. delbrueckii produced elevated levels of IL-12, IFN-γ and TNF-α but no IL-10. IFN-γ production was IL-12 dependent with NK cells as the main source. Furthermore, PBMC infected with Leishmania amazonensis presented elevated microbicidal activity when co-incubated with Lact. delbrueckii. Finally, Lact. delbrueckii was capable of inducing in vitro differentiation of L. amazonensis-specific Th1 cells. These findings suggest that this probiotic may be used as an adjuvant in vaccination protocols.
INTRODUCTION
The immune response to several pathogens, such as Leishmania sp., Trypanosoma cruzi, Toxoplasma gondii and Listeria monocytogenes is dependent on the development of Th1 lymphocytes specific to the pathogen (1-4). It is assumed that vaccine development against such pathogens would require the development of a strong Th1 response that generally is not achieved by the simple inoculation of antigens from the pathogens. Hence, the study of adjuvants that would increase this response is greatly needed.
Several species of Lactobacillus have already been studied in their ability to induce cytokine production (5-8). However, data available in the literature shows that there is great variability amongst the several species/strains of Lactobacillus regarding the profile of cytokines induced by these bacteria (9, 10) . Lactobacillus delbrueckii UFV H2b20 was isolated from feces of a newborn child and is currently being evaluated as a probiotic. Previous studies from our group showed that this strain increases macrophage activation in mice, accelerating the clearance of Escherichia coli from the blood of gnotobiotic mice (11) . Furthermore, Lact. delbrueckii also induces the production of IFN-γ by spleen cells from normal mice (our unpublished results). In view of these findings, we decided to evaluate the ability of Lact. delbrueckii to induce in vitro production of pro-inflammatory cytokines by PBMC and also to test its use as a possible adjuvant capable of inducing the differentiation of naïve lymphocytes into Th1 cells. Our results show that Lact. delbrueckii not only induces the cytokines necessary for T cell differentiation (IL-12, TNF-α and IFN-γ), without increasing the production of anti-inflammatory cytokines (IL-10), but also that the amount of cytokines produced is sufficient to drive in vitro differentiation of T cells, suggesting that this probiotic candidate may be used as an adjuvant in vaccination protocols where the development of a Th1 response is necessary.
MATERIALS AND METHODS

Subjects
A total of 27 healthy volunteers were recruited for this study. Volunteers were from both sexes (17 male) ageing between 19 and 50 years (median 22). Volunteers were asked to answer a questionnaire and only participated in the study after signing an informed consent. This study has been approved by the ethical committee of Universidade Federal de Ouro Preto and is in agreement with the guidelines of the Brazilian Ministry of Health.
Microorganisms
Lactobacillus delbrueckii UFV H2b20, a strain of human origin, was isolated at the Federal University of Viçosa, Minas Gerais, Brazil. Lact. delbrueckii was maintained at -70°C in non-fat reconstituted dry milk containing 20% glycerol. The strain was grown in de Man, Rogosa and Sharp (MRS) broth (Merck) for 18 h at 37°C as previously described . Bacteria in the stationary growth phase were harvested by centrifugation (2000 g, 15 min, 5°C), washed three times with sterile PBS and subsequently adjusted to a final concentration of 10 10 c.f.u./ ml in PBS. Bacteria were heat killed (121°C, 15 min).
Leishmania amazonensis (IFLA\BR\67\PH8) were cultured in Grace´s Medium supplemented with 20% fetal bovine serum (Nutricell, Campinas, SP, Brazil) and 50 mM garamicine. Metacyclic forms were isolated as described by Courret et al. (1999) and used to infect PBMC at a 3:1 parasite/cell ratio. Leishmania antigen was prepared by several cycles of freezing -thawing of stationary phase (five days of culture) promastigotes (12) .
PBMC isolation
Peripheral blood mononuclear cells from healthy volunteers were isolated from blood samples over a FicollHypaque gradient (13) and diluted to 3 x 10 6 cells/ml in RPMI 1640 supplemented with 10% of fetal bovine serum, 50 mM garamicine, 2 mM L-glutamine, 50 µM mercaptoethanol and 25 mM HEPES.
Leishmanicidal Activity
For the evaluation of leishmanicidal activity, PBMC were added in duplicate to round cover slips placed in the bottom of flat-bottom 24-well tissue culture plates. Cells were infected with metacyclic promastigotes of L. amazonensis in a 3:1 parasite/cell ratio in the presence or absence of Lact. delbrueckii for 72h at 37°C, 5% CO 2 . A total of 200 macrophages/monocytes were analyzed and the percentages of infected cells, as well as the number of parasites per cell, were evaluated by optical microscopy of the cover slips stained by a modified Romanowsky method (Panótico Rápido, Laborclin).
Depletion of NK cells
CD56 + NK cells were isolated from PBMC by magnetic cell sorting (MACs) using a negative selection kit according to manufacturers instructions (NK cell isolation kit -Miltenyi Biotec). The degree of cell depletion was confirmed by flow-cytometry analysis.
Cytokine production
For the evaluation of cytokine production by total PBMC and PBMC depleted of NK cells triggered by Lact. delbrueckii stimulus, cells were stimulated with heat-killed bacteria at a 10:1 and 50:1 bacteria/cell ratio at 37°C, 5% CO 2 , in the presence or absence of the anti-IL-12 monoclonal antibody (C8.6.2) (100 µg/ ml -final concentration). Culture supernatants were collected after 24 h for cytokine evaluation. IFN-γ and IL-12 were measured in supernatants from PBMC by sandwich ELISA as described by elsewhere (14) . TNF-α  detection was carried out by the same procedure, using mouse anti TNF-α monoclonal antibodies (B1549.2 and biotinylated B1547.1) and for IL-10, 9D7 followed by biotinylated 12G8 monoclonal antibodies. Recombinant cytokines (R&D Systems, Minneapolis, USA) were used as standards.
Induction of Leishmania-specific Th1 lymphocytes
PBMC (3 x 10 6 cells/ml) from volunteers that had not been in contact with Leishmania parasites or antigens were stimulated with L. amazonensis antigen (50 µg /ml) in the presence or absence of heat killed Lact. delbrueckii (50 bacteria per PBMC) and incubated for 14 d at 37°C, 5% CO 2 . After 14 days, cultures were submitted to centrifugation over a Ficoll-Hypaque gradient in order to recover live cells. These were re-stimulated with L. amazonensis antigen alone in the presence of autologous feeder cells previously treated with mitomycin C (50 µg/ml) for 1 h. Culture supernatants were harvested after seven days (21st d) for IFN-γ evaluation and phenotypic characterization of the stimulated cells by flow cytometry was performed.
Flow cytometry analysis
PBMC (2 x 10 5 cells) were washed in sterile PBS and stained with anti-CD3-FITC, CD4-PE and CD8-PE (BD Biosciences, USA) and CD56-PE (Dako A/S, Glostrup, Denmark). Cytometric analysis was performed on FacScan (BD Biosciences) and data analyzed using Win MDI 2.8 software (http://facs.scripps.edu/software.html). 
Statistical analysis
Data were analyzed by paired two tail Student's t test. p ≤ 0.05 was considered significant.
RESULTS
We have previously observed that heat-killed Lact. delbrueckii is able to induce dose-dependent cytokine production by PBMC from normal volunteers 24 h after stimulation (data not shown). In the present study, we expanded these results to a larger number of volunteers. The results shown in Figure 1 demonstrate that, when used at a bacteria:cell ratio of 10:1 or 50:1, Lact. delbrueckii is able to significantly induce IFN-γ, IL-12 and TNF-α production (P < 0.05). We also observed that, at these doses, no IL-10 production, in addition to basal levels, was stimulated by the bacteria, indicating a clear type 1 cytokine profile.
IL-12 is a major inducer of IFN-γ production (15) . However, while T cells can produce IFN-γ independently of the action of IL-12, production of IFN-γ by NK cells is deeply dependent on the presence of IL-12 (16) . Thus, in order to investigate the involvement of NK cells in the production of IFN-γ in our experiments, we decided to inhibit IL-12 activity in our Lact. delbrueckiistimulated cultures. As shown in Figure 2 , the addition of an antibody against IL-12 severely decreased the ability of PBMC to produce IFN-γ upon stimulation with Lact. delbrueckii, suggesting a possible role of NK cells in the IFN-γ production in this system. To further characterize the involvement of NK cells in the IFN-γ production, we depleted these cells from the PBMC pool prior to the incubation with Lact. delbrueckii. We observed that depletion of NK cells (usually greater than 99%) practically abolished IFN-γ production by PBMC (Figure 3 ) implicating these cells as the major source of this cytokine in our experiments.
In order to verify whether the amount of IFN-γ being produced by Lact. delbrueckii-stimulated cells had biological significance, we decided to evaluate the ability of this cytokine to induce macrophage activation. L. amazonensis is an intracellular parasite that inhabits macrophages of its mammalian hosts. Elimination of Leishmania sp. from infected macrophages is dependent on the presence of IFN-γ produced both by NK and T lymphocytes (17) (18) (19) . Thus, we incubated PBMC with L. amazonensis promastigotes in the presence or absence of Lact. delbrueckii and evaluated the development of this Figure 4 , the presence of Lact. delbrueckii in the cultures reduced the number of infected macrophages as well as the number of parasites per cell. The macrophage activation was associated with increased IFN-γ, TNF-α and IL-12 production as shown in Figure 5 . Furthermore, our results showed no significant differences (P > 0.05) in the production of IL-10 (a macrophage deactivating cytokine) by infected cells, regardless of the presence of heat-killed bacteria even though a tendency to a decreased IL-10 production was observed in the presence of the bacteria.
Since the main goal of this study was to investigate the possibility of the use of Lact. delbrueckii as an adjuvant for Th1 induction, we decided to verify if the cytokine production induced by the bacteria would be sufficient to drive the differentiation to naïve T cells into L. amazonensis-specific Th1 cells. To this purpose, we incubated PBMC from normal volunteers with L. amazonensis antigen in the presence or absence of Lact. delbrueckii and compared the ability of these cells to induce the production of IFN-γ upon re-stimulation with the parasite antigen alone. As shown in Figure 6A , cells derived in the presence of Lact. delbrueckii were able to produce significantly more IFN-γ upon re-stimulation with L. amazonensis antigen, suggesting the differentiation of these cells into Th1 cells. Since, as mentioned above, IFN-γ can be produced by several cell types, we characterized the phenotype of the cells present in the culture after the restimulation with the parasite antigen. We observed an increased percentage of CD4 + cells in cultures primed with L. amazonensis antigen in the presence of Lact. delbrueckii when compared to those primed with the parasite alone ( Figure 6B ). On the other hand, no change in the percentage of CD8 + or NK cells was detected. This result suggests that the source of the increased Leishmaniaspecific IFN-γ production could be associated to CD4 + cells.
DISCUSSION
In this study we present data indicating that Lact. delbrueckii UFV H2b20, a probiotic candidate, is able to induce the production of several cytokines by stimulated human PBMC. The ability of lactobacilli to induce cytokine production has been demonstrated in several occasions both in mice and humans. However, the kind of cytokine produced as well as its concentration is dependent on the species/strain of Lactobacillus used. For example, while Lact. paracasei, Lact. rhamnosus and Lact. plantarum were able to induce IL-12 production by human PBMC, only Lact. rhamnosus induced IL-10 production . In addition, Lact. rhamnosus has been shown to induce IFN-γ production while Lact. bulgaricus failed to do so (20) . These studies indicate that the cytokine profile induced by each species/strain of Lactobacillus may show a distinct immunomodulatory potential, which will determine its therapeutic use. In the case of Lact. delbrueckii, we were able to show that this microorganism induces the production of cytokines that are involved with the stimulation of inflammatory responses (Figs. 1A-C) . Furthermore, we also showed that the production of IL-10, an anti-inflammatory cytokine, was not stimulated in our cultures ( Figure 1D ).
In our study, we measured only the levels of the p40 subunit of IL-12, which would not guarantee the presence of significant levels of active IL-12. However, we also demonstrate that, by using a IL-12 neutralizing We did not characterize the molecules involved in the induction of cytokine production in our system. However, several possible candidates can be appointed as responsible for this activity, i.e. lipoteichoic acid, peptidoglycan and unmethylated CpG-containing DNA motifs. These molecules, present in Gram-positive bacteria, such as lactobacilli, have been shown to stimulate cytokine production through the activation of Toll-Like receptors (23) (24) (25) (26) (27) (28) (29) (30) . Current studies are investigating this issue.
A large number of clinical applications for probiotic bacteria have been demonstrated over the years (31) . Amongst the probiotic microorganisms, the use of lactobacilli has been suggested in several occasions and many studies demonstrate the feasibility of their use as live vectors in oral vaccination (32) . However, oral vaccination usually does not induce the development of inflammatory responses necessary for the control of intracellular pathogens, such as Leishmania and Toxoplasma. In these cases, cutaneous immunization is more prone to induce the milieu necessary for Th1 development. A recent study has shown that Lactobacilli have the ability induce the differentiation of Th1 type cells (33) . Our study further expands this observation by showing that lactobacilli may be used as an adjuvant to drive the differentiation of T cells specific to a different antigen other than the bacterium itself. The utilization of non-pathogenic bacteria, or their products, in vaccination protocols has obvious advantages and deserves further investigation. 
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